HER2 inhibitor Enhertu could become the first drug in the antibody-drug conjugate (ADC) class to be delivered subcutaneously – which is a tall order for such a large molecule – rather than by ...
Seagen claims Enhertu (trastuzumab deruxtecan ... include auristatin compounds coupled to an antibody via a linker molecule. The jury in the US District Court for the Eastern District of ...
The Food and Drug Administration (FDA) has approved Enhertu ® (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...
Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics. They are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results